Mostrar el registro sencillo del ítem
dc.contributor.author | Sánchez-Dengra, Barbara | es_ES |
dc.contributor.author | Alfonso, María | es_ES |
dc.contributor.author | Gonzalez-Alvarez, Isabel | es_ES |
dc.contributor.author | Bermejo, Marival | es_ES |
dc.contributor.author | Gonzalez -Alvarez, Marta | es_ES |
dc.contributor.author | Martínez-Máñez, Ramón | es_ES |
dc.date.accessioned | 2024-09-27T18:08:19Z | |
dc.date.available | 2024-09-27T18:08:19Z | |
dc.date.issued | 2023-10 | es_ES |
dc.identifier.issn | 1743-5889 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10251/208929 | |
dc.description.abstract | [EN] Background: Glioblastoma is the most common and lethal brain cancer. New treatments are needed. However, the presence of the blood-brain barrier is limiting the development of new treatments directed toward the brain, as it restricts the access and distribution of drugs to the CNS. Materials & methods: In this work, two different nanoparticles (i.e., mesoporous silica nanoparticles and magnetic mesoporous silica nanoparticles) loaded with ponatinib were prepared. Results & conclusion: Both particles were characterized and tested in vitro and in vivo, proving that they are not toxic for blood-brain barrier cells and they increase the amount of drug reaching the brain when administered intranasally in comparison with the results obtained for the free drug. | es_ES |
dc.description.sponsorship | This work was supported, in part, by the project "NUEVA FORMULACION DE PONATINIB PARA EL TRATAMIENTO DEL GLIOMA" funded by FUNDACION BIENVENIDA NAVARRO-LUCIANO TRIPODI and, in part, by the project [PID2021-123888OB-100] funded by Ministry of Science and Innovation from Spain. B Sanchez-Dengra received a grant from the Ministry of Science, Innovation and Universities of Spain (FPU17/00530) and a complementary grant from the Ministry of Science, Innovation and Universities of Spain (EST19/00010). | es_ES |
dc.language | Inglés | es_ES |
dc.publisher | Future Medicine | es_ES |
dc.relation.ispartof | Nanomedicine | es_ES |
dc.rights | Reserva de todos los derechos | es_ES |
dc.subject | Blood-brain barrier | es_ES |
dc.subject | Glioblastoma | es_ES |
dc.subject | Mesoporous nanoparticles | es_ES |
dc.subject | Ponatinib | es_ES |
dc.subject | Targeted drug delivery | es_ES |
dc.subject.classification | QUIMICA INORGANICA | es_ES |
dc.title | Intranasal administration of molecular-gated mesoporous nanoparticles to increase ponatinib delivery to the brain | es_ES |
dc.type | Artículo | es_ES |
dc.identifier.doi | 10.2217/nnm-2023-0131 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2021-123888OB-I00/ES/REDUCCION DEL TIEMPO DE DESARROLLO DE ANTIVIRALES ORALES MEDIANTE OPTIMIZACION IN VITRO DE FORMULACIONES: MEDICINAS RAPIDAS, SEGURAS Y BIOEQUIVALENTES./ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/MCIU//FPU17%2F00530/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/MCIU//EST19%2F00010/ | es_ES |
dc.rights.accessRights | Cerrado | es_ES |
dc.contributor.affiliation | Universitat Politècnica de València. Escuela Técnica Superior de Ingenieros Industriales - Escola Tècnica Superior d'Enginyers Industrials | es_ES |
dc.description.bibliographicCitation | Sánchez-Dengra, B.; Alfonso, M.; Gonzalez-Alvarez, I.; Bermejo, M.; Gonzalez -Alvarez, M.; Martínez-Máñez, R. (2023). Intranasal administration of molecular-gated mesoporous nanoparticles to increase ponatinib delivery to the brain. Nanomedicine. 18(25):1799-1813. https://doi.org/10.2217/nnm-2023-0131 | es_ES |
dc.description.accrualMethod | S | es_ES |
dc.relation.publisherversion | https://doi.org/10.2217/nnm-2023-0131 | es_ES |
dc.description.upvformatpinicio | 1799 | es_ES |
dc.description.upvformatpfin | 1813 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.description.volume | 18 | es_ES |
dc.description.issue | 25 | es_ES |
dc.identifier.pmid | 37990994 | es_ES |
dc.relation.pasarela | S\511352 | es_ES |
dc.contributor.funder | Agencia Estatal de Investigación | es_ES |
dc.contributor.funder | Ministerio de Ciencia, Innovación y Universidades | es_ES |